Observations on PUVA treatment of psoriasis and on 5-S-cysteinyldopa after exposure to UV light.
D003548:Cysteinyldopa / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D006801:Humans; D011701:PUVA Therapy / Q000009:adverse effects; D010778:Photochemotherapy / Q000009:adverse effects; D011312:Pressure; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism; D012867:Skin / Q000187:drug effects; D012880:Skin Pigmentation / Q000187:drug effects / Q000528:radiation effects; D014466:Ultraviolet Rays / Q000009:adverse effects
D003548:Cysteinyldopa; D004295:Dihydroxyphenylalanine